Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SRD5A2 | P31213 | 4/20 | 0.53 |
| ▸ | GSK3B | P49841 | 3/20 | 0.51 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.51 |
| ▸ | ERCC5 | P28715 | 1/20 | 0.51 |
| ▸ | FEN1 | P39748 | 1/20 | 0.51 |
| ▸ | MMP1 | P03956 | 1/20 | 0.48 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.46 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.46 |
| ▸ | LTA4H | P09960 | 1/20 | 0.45 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1350830 | 0.87 | GSK3B (0.67) | SRD5A2GSK3BPTPN1ERCC5FEN1 | |
| SCHEMBL5324129 | 0.82 | LTA4H (0.57) | SRD5A2FFAR1PARP10LTA4H | |
| SCHEMBL204218 | 0.80 | GSK3B (0.70) | GSK3BPTPN1ERCC5FEN1MMP1 | |
| SCHEMBL4456868 | 0.78 | NR4A1 (0.64) | SRD5A2GSK3BPTPN1FFAR1PARP10 | |
| SCHEMBL203505 | 0.75 | TNKS (0.58) | GSK3BPTPN1ERCC5FEN1PARP10 | |
| SCHEMBL19043378 | 0.75 | MMP1 (0.60) | SRD5A2ERCC5FEN1MMP1FFAR1 | |
| SCHEMBL4744025 | 0.74 | MAPT (0.68) | SRD5A2HPGDPOLBSMN1; SMN2 | |
| SCHEMBL26327986 | 0.74 | MAPT (0.68) | SRD5A2HPGDPOLBSMN1; SMN2 | |
| Phenylacetaldehyde SCHEMBL11036118 | 0.74 | GSK3B (0.69) | GSK3BPTPN1POLBSMN1; SMN2 | |
| SCHEMBL8260473 | 0.74 | GSK3B (0.77) | SRD5A2GSK3BPTPN1ERCC5FEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2006057503-A1 | NOVEL COMPOUNDS AS AGONIST FOR PPARϜ AND PPARα, METHOD FOR PREPARATION OF THE SAME, AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME | LG LIFE SCIENCES, LTD. (KR) | 2006-06-01 | — | — | WO | disclosed |